The AscencioDx COVID-19 Molecular Detector
(1 AscencioDx® Molecular Detector)
The AscencioDx Molecular Detector is a rapid, highly accurate, easy-to-use medical device for conducting NAAT analysis of samples collected from patients in point-of-care (POC) settings with in vitro diagnostic supplies, delivering positive results in as few as 20 minutes. This device is especially beneficial in environments such as physicians' offices, urgent care clinics, pharmacies, and other point-of-care facilities.
Ground Shipping Only. For other shipping options call our customer service line at 888.882.7739
No Returns or Exchanges.
Highlights and Benefits:
Rapid Results: Delivers positive test results in as few as 20 minutes, thus expediting decision-making and enhancing patient care. No need to wait for an inconclusive antigen test or wait for a lab test result to come back.
Re-usable: This reusable device and its lightweight disposable components substantially decrease biowaste. This detector can be used > 4000 times.
Compact Size: Due to its size, this detector is portable and does not monopolize lab counter space.
Easy and Convenient: This CLIA-waived system is incredibly user-friendly and does not require extensive training, making it a suitable choice for all healthcare settings. Transitioning from your current or previous COVID-19 testing platform is easy with minimal cost. The perfect replacement for the Accula™ Dock and test kits.
Efficient Reporting: The platform simplifies test reporting and patient records with its dynamic QR code scanning feature, which allows for effortless logging of test results to our cloud-based Detector Portal. Capturing test results and sharing data just became that much easier.
Quality You Can Rely On: AscencioDx is FDA EUA authorized and we proudly manufacture in the United States to meet our strict quality standards.
Ideal Product Applications: Healthcare professionals, Physician office laboratories, Urgent Care providers, Mobile testing, etc.
Available Assays: COVID-19 today.
Future Products from Anavasi: New products from Anavasi are in development for multiplex respiratory panels and the detection of sexually transmitted infections.
Test Name: The AscencioDx COVID-19 Test
CPT Code: 87635
LOINC Code(s): 95409-9
CPT Code Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
(Coronavirus disease [COVID-19]), amplified probe technique
Medicare Reimbursement: $51.31